SNAI2 and glioblastoma: Euchromatic histone-lysine N-methyltransferase 2 inhibitor BIX01294 (Bix) increases the aggressive behaviour of GBM cells by modulating the activity of EMT markers, such as E-cadherin, N-cadherin, β-catenin and Slug [130].